Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haplo-identical”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00849147
What this trial is testing

Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)

Who this might be right for
Precursor B-Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteBurkitt Lymphoma+3 more
Medical College of Wisconsin 55
Large-scale testing (Phase 3)Study completedNCT03719534
What this trial is testing

Haplo HCT vs Haplo-cord HCT for Patients With AML

Who this might be right for
Hematopoietic Stem Cell TransplantationHaplo-identical DonorCord Blood Unit+1 more
The First Affiliated Hospital of Soochow University 134
Early research (Phase 1)Study completedNCT00089453
What this trial is testing

Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
University of Arkansas 10
Testing effectiveness (Phase 2)Ended earlyNCT02127892
What this trial is testing

SCID Bu/Flu/ATG Study With T Cell Depletion

Who this might be right for
Severe Combined Immunodeficiency
Neena Kapoor, M.D. 9
Not applicableStudy completedNCT05243498
What this trial is testing

Allogenomic Mismatch Score (AMS) Applied to Haplo-identical Donor/Recipient Pairs in Haematopoietic Stem Cell Transplantation

Who this might be right for
Stem Cell TransplantationHaplo-identical
Central Hospital, Nancy, France 80
Testing effectiveness (Phase 2)WithdrawnNCT04395092
What this trial is testing

Haplo-identical Natural Killer (NK) Cells to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM)

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndromes (MDS)
Kiadis Pharma
Testing effectiveness (Phase 2)Looking for participantsNCT03670966
What this trial is testing

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia in Remission+9 more
Fred Hutchinson Cancer Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT05664126
What this trial is testing

Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation

Who this might be right for
CytomegalovirusAdenovirus
St. Jude Children's Research Hospital 42
Large-scale testing (Phase 3)Study completedNCT02042690
What this trial is testing

Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients

Who this might be right for
Acute Lymphoblastic Leukemia
Peking University 131
Testing effectiveness (Phase 2)Study completedNCT00673114
What this trial is testing

Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies

Who this might be right for
Hematologic MalignancyMyelodysplastic Syndrome (MDS)Aplastic Anemia
Joanne Kurtzberg, MD 3
Large-scale testing (Phase 3)Ended earlyNCT00616954
What this trial is testing

Evaluate the Effect of ATG-F on Engraftment, Graft Versus Host Disease (GVHD) and Graft Versus Leukemia (GVL) Effect in Haplo-identical SCT

Who this might be right for
Allogeneic Haplo-Stem Cell Transplatation (SCT)Graft Versus Host Disease
Hadassah Medical Organization 50
Early research (Phase 1)Study completedNCT02660281
What this trial is testing

URMC Related Haplo-identical Donor BMT

Who this might be right for
Hematological DiseaseImmune DeficienciesSolid Tumors+3 more
University of Rochester 74
Early research (Phase 1)Looking for participantsNCT05066412
What this trial is testing

Prophylactic CD45RA-depleted DLI After Haploidentical Transplantation/RIC

Who this might be right for
Hematologic MalignancyHaplo-identical Stem Cell Transplantation
University Hospital, Geneva 12
Not applicableLooking for participantsNCT05417971
What this trial is testing

Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation

Who this might be right for
Hematologic Malignancy
Northside Hospital, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT01682226
What this trial is testing

Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies

Who this might be right for
LeukemiaMyelodysplastic SyndromeLymphoma
Memorial Sloan Kettering Cancer Center 84
Testing effectiveness (Phase 2)Study completedNCT04686929
What this trial is testing

Abatacept s.c. for aGVHD Prevention in Haplo-HCT

Who this might be right for
AbataceptAcute-graft-versus-host DiseaseHaplo-identical HCT+1 more
The First Affiliated Hospital of Soochow University 29
Very early researchActive Not RecruitingNCT03910452
What this trial is testing

Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide

Who this might be right for
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID) 4
Not applicableStudy completedNCT01793675
What this trial is testing

Haplo-identical/Mismatched Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome

Who this might be right for
Advanced MDS Without Identical Sibling Donor
Peking University People's Hospital 116
Testing effectiveness (Phase 2)Looking for participantsNCT07662369
What this trial is testing

CD45RA-depleted DLI for the Treatment of Refractory/Persistent Viral Infections After Haploidentical Transplantation

Who this might be right for
Hematologic MalignancyHaplo-identical HCT
Ruijin Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00957931
What this trial is testing

Allo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCs

Who this might be right for
Sickle Cell DiseaseThalassemiaDiamond-Blackfan Anemia
Stanford University 6
Next Page